Literature DB >> 18404570

Novel N-3 substituted TSAO-T derivatives: synthesis and anti-HIV-evaluation.

María-Cruz Bonache1, Ernesto Quesada, Chih-Wei Sheen, Jan Balzarini, Nicolas Sluis-Cremer, María Jesús Pérez-Pérez, María-José Camarasa, Ana San-Félix.   

Abstract

Novel derivatives of the anti-HIV-1 agent, TSAO-T, bearing at the N-3 position alkylating groups or photoaffinity labels were prepared and evaluated for their anti-HIV activity. All of these compounds demonstrated pronounced anti-HIV-1 activity and inhibited HIV-1 RT; however, we were unable to detect stable covalent linkages between inhibitor and enzyme. In addition, compounds with an alcohol functional group connected to the N-3 position through a cis or trans double bond have been prepared. These compounds have been useful to study how the conformational restriction of the linker affects in the interaction between the N-3 substituent and the HIV-1 RT enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18404570     DOI: 10.1080/15257770801943990

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  2 in total

1.  Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocket.

Authors:  Kalyan Das; Joseph D Bauman; Angela S Rim; Chhaya Dharia; Arthur D Clark; María-José Camarasa; Jan Balzarini; Eddy Arnold
Journal:  J Med Chem       Date:  2011-03-29       Impact factor: 7.446

2.  Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H.

Authors:  Suhman Chung; Michaela Wendeler; Jason W Rausch; Greg Beilhartz; Matthias Gotte; Barry R O'Keefe; Alun Bermingham; John A Beutler; Shixin Liu; Xiaowei Zhuang; Stuart F J Le Grice
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.